Behind the Knife ABSITE 2026: Comprehensive Breast Pathology Review
Behind The Knife: The Surgery PodcastJanuary 3, 20261h 9min472 views
19 connectionsΒ·40 entities in this videoβBreast Anatomy and Axillary Dissection
- π Axillary lymph node levels are defined by their relationship to the pectoralis minor muscle: Level I is lateral, Level II is posterior, and Level III is medial.
- β οΈ For breast cancer, axillary lymph node dissection typically involves Levels I and II, whereas melanoma dissections include all three levels.
- β‘ Key nerves at risk during axillary dissection include the long thoracic nerve (serratus anterior, winged scapula), thoracodorsal nerve (latissimus dorsi, weakness in abduction), and intercostobrachial nerve (sensory deficits to the medial arm).
- π‘ The medial pectoral nerve innervates both pectoralis major and minor, while the lateral pectoral nerve innervates only the pectoralis major.
- π©Έ Blood supply to the breast comes from the internal thoracic, intercostal, lateral thoracic, and thoricoacromial arteries.
- π§ Batson's plexus is a valveless venous plexus that allows for direct hematogenous spread to the spine, a significant consideration for metastatic disease.
Benign Breast Lesions and Pathology
- π‘ Breast pain is often self-limited and cyclical; management ranges from reassurance and dietary supplements to medications like tamoxifen or danazol for refractory cases.
- β οΈ Mondor's disease is a superficial thrombophlebitis of a breast vein, presenting as a tender, palpable cord, treated with NSAIDs and warm compresses.
- π Benign breast lesions are categorized by malignancy risk: non-proliferative (no increased risk), proliferative without atypia (mild increased risk, e.g., papilloma, sclerosing adenosis), and proliferative with atypia (higher risk, e.g., atypical ductal/lobular hyperplasia).
- π¬ Simple cysts are managed with observation if asymptomatic; symptomatic or bloody cysts may require aspiration or surgical excision.
- βοΈ Complex cysts with solid components or internal vascularity require core needle biopsy.
- π― Fibroadenomas present as dominant masses, typically imaged with ultrasound (under 35) or mammography (over 35); surveillance is common for benign findings, with excisional biopsy for enlarging masses or uncertainty.
- π Giant fibroadenomas (>6 cm) can be difficult to distinguish from phyllodes tumors.
- β οΈ Complex fibroadenomas (with sclerosing adenosis, papillary hyperplasia, etc.) carry an increased risk for carcinoma.
- π Phyllodes tumors have benign, borderline, and malignant classifications, spread hematogenously, and are treated with wide local excision with negative margins.
- π§ Nipple discharge is most commonly caused by intraductal papilloma; bloody, spontaneous, persistent, or unilateral discharge is concerning for malignancy, especially in older women.
- π¬ Duct ectasia involves dilation of subareolar ducts, presenting with viscous nipple discharge, managed with observation if asymptomatic or excision if symptomatic.
- π¦ Staphylococcus aureus is the most common pathogen in both lactational and non-lactational breast infections; treatment for lactational mastitis without abscess is antibiotics, while abscesses may require aspiration.
- β οΈ Inflammatory breast cancer presents like an infection but requires skin biopsy to rule out dermal lymphatic invasion; it is treated with neoadjuvant chemotherapy, modified radical mastectomy, and adjuvant chemo-radiation.
- π Paget's disease of the nipple presents with eczematous changes and is a marker for underlying DCIS or invasive cancer, requiring mastectomy with sentinel lymph node biopsy.
Breast Cancer: Diagnosis and Staging
- π Screening mammography typically starts at age 40 for low-risk women, annually after 50, and earlier for high-risk individuals (e.g., 10 years before youngest affected relative).
- 𧬠BRCA mutations significantly increase breast and ovarian cancer risk, necessitating earlier and more intensive screening (mammography, MRI, pelvic exams).
- π BI-RADS categories range from 0 (incomplete) to 6 (biopsy-proven malignancy), with BI-RADS 3 indicating probable benignity requiring 6-month follow-up.
- π― Gail model estimates 5-year and lifetime breast cancer risk, considering age, reproductive history, family history, and prior biopsies; it may underestimate risk in BRCA mutation carriers.
- βοΈ NCCN staging for invasive breast cancer involves T (tumor size), N (nodal involvement), and M (metastasis) categories, with Stage I being small tumors with no nodes and Stage IV involving distant metastasis.
- 𧬠Ancotype DX score analyzes 21 genes to predict recurrence risk and chemotherapy benefit in ER-positive, HER2-negative tumors (Stage I-IIIA).
- π¬ Ductal carcinoma is the most common type; lobular carcinoma is less common and doesn't typically form calcifications; signet ring cell subtype has the worst prognosis.
Breast Cancer Treatment and Management
- π‘ Breast conservation therapy (lumpectomy with radiation) is equivalent to mastectomy for overall survival but has higher local recurrence rates if radiation is omitted.
- β οΈ Contraindications to breast conservation include pregnancy, multicentric disease, positive margins after re-excision, and previous radiation.
- π Adjuvant chemotherapy is indicated for tumors >1 cm, positive nodes, triple-negative tumors, or high Oncotype DX scores.
- π Neoadjuvant chemotherapy is used for locally advanced or inoperable tumors (e.g., inflammatory, T4, N2/N3) and HER2-positive tumors >1 cm.
- β’οΈ Radiation therapy after mastectomy is indicated for advanced nodal disease (>4 nodes, fixed nodes, internal mammary nodes), skin/chest wall involvement, positive margins, or T3/T4 tumors.
- πΈ Endocrine therapy (tamoxifen for premenopausal, aromatase inhibitors for postmenopausal women) is used for ER/PR-positive tumors.
- π― HER2-targeted therapy (trastuzumab) is used for HER2-positive tumors, with a worse prognosis but specific treatment options.
- π Nodal status is the most critical prognostic factor; the Z11 trial demonstrated no benefit from axillary dissection for T1-T2 tumors with <3 positive sentinel nodes receiving breast conservation and radiation.
- ποΈ Breast reconstruction options include implant-based and autologous flaps (e.g., TRAM, DIEP); flap necrosis is most commonly caused by venous thrombosis.
- π« Immediate reconstruction is contraindicated in inflammatory breast cancer.
- π©Έ Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare lymphoma associated with textured implants, presenting with fluid collections around the implant.
- 𦴠Metastasis commonly occurs to bone, lung, brain, and liver; isolated tumor cell deposits (<0.2 mm) do not constitute metastatic disease.
- 𧬠BRCA1 carries a ~65% breast and ~40% ovarian cancer risk; BRCA2 carries a ~45% breast and ~10% ovarian cancer risk.
- π Tamoxifen side effects include thromboembolism and increased uterine cancer risk but is protective against osteoporosis; aromatase inhibitors increase osteoporosis risk.
- ποΈ Stewart-Treves syndrome is a lymphangiosarcoma developing in chronic lymphedema.
Knowledge graph40 entities Β· 19 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
40 entities
Chapters5 moments
Key Moments
Transcript258 segments
Full Transcript
Topics31 themes
Whatβs Discussed
ABSITE ReviewBreast PathologyAxillary Lymph NodesBenign Breast LesionsFibroadenomaPhyllodes TumorNipple DischargeBreast InfectionsInflammatory Breast CancerPaget's Disease of the BreastBreast Cancer ScreeningBI-RADSGail ModelBRCA MutationsBreast Cancer StagingAncotype DX ScoreDuctal CarcinomaLobular CarcinomaBreast Conservation TherapyMastectomyAdjuvant ChemotherapyNeoadjuvant ChemotherapyRadiation TherapyEndocrine TherapyHER2 Targeted TherapySentinel Lymph Node BiopsyAxillary DissectionBreast ReconstructionFlap NecrosisMetastasisStewart-Treves Syndrome
Smart Objects40 Β· 19 links
ConceptsΒ· 28
ProductsΒ· 11
CompanyΒ· 1